Letizia Procaccio

4PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Somaieh Hedayat, Luciano Cascione, David Cunningham

|May 28, 2022
Simultaneous Care in Oncology: A 7-Year Experience at ESMO Designated Centre at Veneto Institute of Oncology, Italy.

Antonella Brunello, Antonella Galiano, Stefania Schiavon

|Feb 24, 2022
An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer.

Alessandra Anna Prete, Letizia Procaccio, Francesca Bergamo

|Oct 23, 2021
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.

Letizia Procaccio, Francesca Bergamo, Francesca Daniel

Pageof 1